The co-founders of California-based multistate marijuana operator MedMen are fully out of the corporate, having relinquished their roles on the board of administrators.

According to a information launch, former CEO Adam Bierman stepped down from his seat on the board, and ex-president Andrew Modlin left his publish as an “observer” to the board.

In addition, Modlin’s employment settlement expired May 18, the discharge famous.

Their departures from the MedMen board follows the twin resignations in January of Bierman and Modlin as CEO and president, respectively.

Until now, nevertheless, they’d stored a semblance of roles with the Los Angeles firm through the board.

The firm beforehand said that Modlin additionally pledged to relinquish his tremendous voting shares in MedMen by December.

The resignations haven’t stored hassle from following MedMen, nevertheless.

In April, a MedMen creditor mentioned it was in search of to grab Bierman and Modlin’s private properties as partial compensation for a debt.

And in May, Nevada regulators started trying into an allegation by former MedMen Chief Financial Officer James Parker that Bierman and Modlin made unlawful marketing campaign donations to the state’s governor.

MedMen trades on the Canadian Securities Exchange as MMEN and on the U.S. over-the-counter markets as MMNFF.

Source link